key: cord-1004635-mhuebpsh
authors: Guo, Yi; Zhang, Yahan; Lyu, Tianchen; Prosperi, Mattia; Wang, Fei; Xu, Hua; Bian, Jiang
title: The application of artificial intelligence and data integration in COVID-19 studies: a scoping review
date: 2021-06-21
journal: J Am Med Inform Assoc
DOI: 10.1093/jamia/ocab098
sha: 0754031f405e9fdc61a3eeb0a914e58603a9b336
doc_id: 1004635
cord_uid: mhuebpsh

OBJECTIVE: To summarize how artificial intelligence (AI) is being applied in COVID-19 research and determine whether these AI applications integrated heterogenous data from different sources for modeling. MATERIALS AND METHODS: We searched 2 major COVID-19 literature databases, the National Institutes of Health’s LitCovid and the World Health Organization’s COVID-19 database on March 9, 2021. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, 2 reviewers independently reviewed all the articles in 2 rounds of screening. RESULTS: In the 794 studies included in the final qualitative analysis, we identified 7 key COVID-19 research areas in which AI was applied, including disease forecasting, medical imaging-based diagnosis and prognosis, early detection and prognosis (non-imaging), drug repurposing and early drug discovery, social media data analysis, genomic, transcriptomic, and proteomic data analysis, and other COVID-19 research topics. We also found that there was a lack of heterogenous data integration in these AI applications. DISCUSSION: Risk factors relevant to COVID-19 outcomes exist in heterogeneous data sources, including electronic health records, surveillance systems, sociodemographic datasets, and many more. However, most AI applications in COVID-19 research adopted a single-sourced approach that could omit important risk factors and thus lead to biased algorithms. Integrating heterogeneous data for modeling will help realize the full potential of AI algorithms, improve precision, and reduce bias. CONCLUSION: There is a lack of data integration in the AI applications in COVID-19 research and a need for a multilevel AI framework that supports the analysis of heterogeneous data from different sources.

In just a few months, the 2019 novel coronavirus disease (COVID- 19) , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread around the globe, and at the time of this writing, there are over 100 million confirmed COVID-19 cases and a few million confirmed deaths from COVID-19 worldwide. 1 The COVID-19 pandemic is now the second deadliest pandemic in over 100 years, behind only the 1918 influenza pandemic (ie, Spanish Flu). 2 While the COVID-19 pandemic is still raging, and the number of cases are growing exponentially, the scientific communities around the world have reacted promptly by directing effects and resources to research studies on the etiology, transmission, detection, treatment, and prevention and control of COVID-19. In about a year, an outstanding number of over 100 000 research articles on COVID-19-related topics have been published according to PubMed. 3 Recent advances in artificial intelligence (AI) have provided novel methods and tools for combating global pandemics, such as COVID- 19 . In classic computer science textbooks, AI is broadly defined as the study of intelligent agents, machines or devices that can imitate human cognitive functions to learn the environment and take actions. 4 The learning process is often implemented through mathematical or statistical models in computer programs. Machine learning, of which deep learning is a subset, is a branch of AI that trains algorithms that allow computer programs to automatically (ie, without explicit programming) improve through data. 5 In the fields of public health and medicine, AI techniques-especially machine learning and, more recently, deep learning methods-have been widely used for disease surveillance, health risks and outcomes prediction, medical diagnostics and therapeutics, clinical decision-making, and many more. [6] [7] [8] With surveillance tools, patient reporting systems, and clinical studies emerging quickly, large amounts of novel data have been rapidly accumulated during the COVID-19 pandemic. There is growing interest in leveraging these data to develop AI solutions for COVID-19 challenges. However, developing AI models in the era of precision health is not a trivial task. Precision health adopts a unified approach to understanding the full range of determinants of health for health promotion, prevention, diagnosis, and treatment. 9 , 10 The vision of precision health can only be realized through the integration and examination of a comprehensive list of determinants of health that include genetic, biological, environmental, as well as social and behavioral factors. On the other hand, these determinants of health exist in various data sources that are heterogeneous in syntax (eg, file formats), schema (eg, data models and structures), and semantics (eg, meanings or interpretations of the variables). One of the first and most important challenges in building precision health AI models is integrating relevant data that contain determinants of health from the heterogeneous sources.

In this study, we conducted a scoping review of AI applications in COVID-19 research with a focus on heterogeneous data integration. Our goal was to summarize the COVID-19 research areas in which AI is being applied, the AI models being used in these research applications, and the data sources being used to build the AI models. We were particularly interested in examining whether these AI applications integrated heterogenous data from different sources for building the models and treated missing data in the variables of interest. Although a few published reviews have summarized the applications of AI or machine learning methods in COVID-19 research, [11] [12] [13] [14] [15] none of them examined data integration, and many focused on a specific area of COVID-19 research (eg, medical imaging 15 ). Note that we focused on the use of AI methods for data analysis and excluded other AI fields, such as robotics.

We searched 2 major COVID-19 literature databases, the National Institutes of Health (NIH) LitCovid (part of PubMed) 3 and the World Health Organization (WHO) COVID-19 database 16 for articles published through March 9, 2021. LitCovid is an openresource literature hub developed by the NIH for tracking up-todate scientific information about COVID-19. It provides a central access to all COVID-19-related articles in PubMed. 3 The WHO COVID-19 database contains global literatures of scientific findings and knowledge on COVID-19 gathered by the WHO. 16 Both databases are updated daily with newly published articles. The following query and keywords were used to search the databases: "artificial Intelligence" or "machine learning" or "supervised learning" or "unsupervised learning" or "deep learning" or "neural networks" or "natural language processing."

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, 17 we screened the articles retrieved from the databases in 2 rounds. First, we screened the titles and abstracts of the identified articles and excluded those that: (1) did not use any AI methods for data analysis, (2) were unrelated to COVID-19, (3) were reviews, editorials, opinions, letters to editor, or case reports, or (4) were not written in English. Second, we screened the full texts of the remaining articles to further exclude articles that met our exclusion criteria. Two reviewers (YZ and TL) independently reviewed all the articles in the 2 rounds of screening. Any conflicts between the 2 reviewers were reviewed and solved by a third reviewer (YG). We extracted and summarized COVID-19and AI-related information from the retained articles.

We summarized our review procedure in a PRISMA flow diagram in Figure 1 . We identified 1311 and 1218 studies in the LitCovid and WHO COVID-19 databases, respectively. After removing duplicated studies, we included 1338 studies in the first round of screening. In the first round of screening of titles and abstracts, 492 studies were excluded according to our exclusion criteria, while 846 studies were included in the full-text review. In the second round of screening, another 52 studies were excluded based on full-text review and eventually, 794 studies were included in the final qualitative analysis.

The AI applications covered in these 794 studies can be categorized into the following areas of COVID-19 research: Disease forecasting (n ¼ 161), Medical imaging-based diagnosis and prognosis (n ¼ 322); Early detection and prognosis (non-imaging) (n ¼ 152); Drug repurposing and early drug discovery (n ¼ 53); Social media data analysis (n ¼ 44); Genomic, transcriptomic, and proteomic data analysis (n ¼ 24); and Other COVID-19 research topics (survey studies, literature mining, surveillance, clinical trials, miscellaneous topics) (n ¼ 38). We listed the full citations of all 794 studies by research area in the Supplementary Table S1. In the following sections, we summarized what and how AI techniques were applied in these areas. In particular, we determined whether the studies integrated heterogeneous data to expand the list of inputs (or predictors) for building the AI models. In line with Lenzerini 2002, 18 we defined data integration as the action of combining data that are heterogeneous in syntax, schema, and semantics and extracting predictors from these data for modeling. The total number of studies and the number of studies with data integration in each research area were summarized in Figure 2 .

A total of 161 studies described the use of AI for COVID-19 forecasting (Supplementary Table S1 ). In these studies, 106 predicted future COVID-19 incidence or mortality using historical data only, 43 predicted future or confirmed COVID-19 cases using potential risk factors as inputs, 8 characterized country-level differences in COVID-19 outcomes worldwide (clustering studies), and 4 predicted future demands for hospital resources or medical consumables.

The majority of the 106 studies on predicting future COVID-19 incidence or mortality used COVID-19 data from the Johns Hopkins University Center for Systems Science and Engineering, 19 or local health authorities. In these studies, the long short-term memory (LSTM), a class of recurrent neural networks (RNN), was the most commonly used deep learning model. Other popular models included other types of artificial neural networks (ANN); machine learning models, such as random forest, support vector machines (SVM), and gradient boosting machine (GBM); statistical time series models, such as the autoregressive integrated moving average (ARIMA) model; and epidemiological models, such as the Susceptible-Infectious-Recovered and Susceptible-Exposed-Infected-Removed models. None of the 106 studies integrated heterogeneous data for modeling since only historical COVID-19 data were used as inputs.

In the 43 studies on COVID-19 risk factors, 27 examined environmental exposures, while the remaining 16 examined a range of other risk factors, such as population characteristics, socioeconomic status, or other health-related factors. Most of these studies used machine learning models, among which random forest and GBM were the most popular algorithms. A small portion of these studies used ANN, among which the multilayer perceptron (MLP) was the most popular. Among these 43 studies, slightly over half (n ¼ 24, 55.8%) integrated heterogeneous data on predictors for modeling ( used simple mean or median imputation, while the third study used the k-nearest neighbor (k-NN) method (Table 1) . All 8 clustering studies used unsupervised machine learning models, with the most popular model being the k-means. These studies aimed to group and compare countries or regions based on COVID-19 incidence, risks, and preparedness or performance. Half of the studies (n ¼ 4, 50.0%) integrated heterogeneous data for modeling ( Table 1 ). One of the 4 studies imputed missing data with mean values ( Table 1) .

The 4 studies on future demands predicted the need for intensive care unit (ICU) beds or medical consumables (eg, face masks) using data on COVID-19 cases or on consumable sales or production. All 4 studies used ANN (eg, MLP) or RNN (eg, LSTM), with some studies also building machine learning models. None of the studies integrated heterogeneous data for modeling.

A total of 322 studies described the use of AI for analyzing medical imaging data for COVID-19 diagnosis and prognosis (Supplementary Table S1 ). All studies analyzed either computed tomography or chest X-ray data, except for 5 studies that analyzed images of lung ultrasound [48] [49] [50] [51] or skin lesions. 52 The most common sources of medical images were local hospitals or healthcare systems and image datasets published on public domains, such as GitHub or Kaggle. In these imaging studies, roughly half used the convolutional neural network (CNN)-based models. More than 90% of these studies predicted COVID-19 outcomes using medical imaging data alone. Only 29 out of the 322 studies (9.0%) considered data from heterogenous sources for AI modeling (Table 2 ). In addition to imaging data, these studies considered influences from demographics (eg, age, sex, etc), clinical characteristics (eg, symptoms, lab results, disease history, etc), and other human factors (eg, exposure history) on COVID-19 outcomes. Five of these studies imputed missing data using simple mean or median imputation (Table 2) .

A total of 152 studies described the use of AI for COVID-19 early detection (n ¼ 52) and prognosis (n ¼ 100) (Supplementary Table  S1 ). The vast majority of the studies on COVID-19 early detection analyzed COVID-19 positivity (þ vs À, determined by the reverse transcription polymerase chain reaction test) as the study outcome using patient data from hospitals or healthcare systems. A wide range of AI models were used for prediction, although machine learning models (eg, random forest, GBM) were used more often than deep learning models. Furthermore, most studies used a single type of data for COVID-19 detection, such as lab test data (eg, blood cell counts or inflammatory biomarkers) or clinical symptoms. Only 8 out of the 47 studies (17.0%) integrated heterogenous data for modeling (Table 3 ). In addition to lab and symptom data, these studies considered data on comorbidity, medications, travel/ contact history, etc.

The vast majority of the studies on COVID-19 prognosis examined hospitalization, ICU admission, mechanical ventilation requirements, and/or death in COVID-19 patients using data from hospitals or healthcare systems. Traditional machine learning models were preferred over deep learning models, with the most popular model being random forest. Only 21 out of the 92 studies (22.8%) integrated heterogenous data for modeling (Table 3) . These heterogenous data included demographics, clinical data (eg, lab, disease and medication history, and symptoms), genetic sequencing data, exposure history, etc.

In the early detection and prognosis studies that integrated heterogenous data (Table 3) , 8 studies imputed missing data. Most studies performed simple imputation based on mean, mode, or median values, while 2 studies performed multivariate imputation by chained equations, 100,104 and 1 study imputed missing values using bagging trees. 96 Drug repurposing and early drug discovery A total of 53 studies described the use of AI for drug repurposing (36 studies) or early COVID-19 drug discovery (18 studies) (Supplementary Table S1 ). The majority of the studies focused on screening for candidate drugs in biomolecule or drug databases. Popular data sources included DrugBank (Food and Drug Administration [FDA]approved and experimental drugs), 110 ChEMBL (bioactivity database for drug discovery), 111 PubChem (substance and compound databases), 112 ZINC (commercially available compounds for virtual screening), 113 BindingDB (experimentally determined protein-ligand binding affinities). 114 Deep learning models (eg, CNN, RNN) were used more often than the machine learning models. Furthermore, 5 out of the 36 drug repurposing studies mined the literature for repurposable drugs. [115] [116] [117] [118] [119] All 5 studies used NLP-based methods to mine scientific literature or other relevant data. For example, 1 study examined the description of over 1.2 million bioassays in the ChEMBL database to identify COVID-19-related bioassays. 115 The 18 studies on early drug discovery mainly focused on screening for potential biomolecules (eg, virtual ligand screening) in ligand or compound databases (eg, ChEMBL, PubChem, ZINC, Bind-ingDB) that could target SARS-CoV-2 functional domains. Similarly, deep learning models were preferred over the machine learning models. None of drug repurposing or early drug discovery studies integrated heterogeneous data for modeling.

A total of 44 studies described the use of AI for analyzing social media data (Supplementary Table S1 ). In these studies, Twitter was the single most popular data source, with 32 studies analyzing tweets from all over the world. The other 12 studies used data from Facebook, Reddit, YouTube, Weibo, etc. Most social media studies adopted a similar analytic approach: NLP methods and tools for text extraction and processing, followed by topic modeling and/or a sentiment analysis. The most common method for topic modeling was the latent Dirichlet allocation, whereas a range of machine learning models were used for sentiment analysis including SVM, Naïve Bayes, k-NN, random forest, etc. None of the social media studies integrated heterogeneous data for modeling.

Genomic, transcriptomic, and proteomic data analysis A total of 24 studies described the use of AI for analyzing SARS-CoV-2 sequence data (eg, ribonucleic acid [RNA], small interfering RNA [siRNA ], or protein sequences) (Supplementary Table S1 ). One common analysis goal of many of these studies was to determine the unique SARS-CoV-2 RNA or protein features that could potentially be targeted for disease detection and drug or vaccine design. Over half of these studies analyzed the SARS-CoV-2 genome sequences in the National Center for Biotechnology Information GenBank. 120 Other data sources included the Protein Data Bank, 121 National Genomics Data Center of China, 122 or self-generated sequence data. A wide variety of AI models were used in these studies, including the deep learning models (CNN, RNN) and the traditional machine learning models (k-NN, SVM, random forest, GBM). None of the studies integrated heterogeneous data for modeling.

Survey studies A total of 14 survey studies used AI models for studying COVID-19related topics in various populations around world (Supplementary Table S1 ). The most common study outcomes were self-reported fear, stress, anxiety, and depression related to the pandemic. The majority of the studies used machine learning models, including random forest, XGBoost, SVM, and Naïve Bayes. Two of the studies, 123, 124 which were based on the same online survey, collected text data using open-ended questions. These studies performed a sentiment analysis that involved sentiment scores calculation and clustering using the k-mean algorithm. None of the survey studies integrated heterogeneous data for modeling.

A total of 10 studies described the use of AI for mining COVID-19 literature (Supplementary Table S1 ). Literature mining studies on drug repurposing were summarized in a previous section. These 10 studies focused on summarizing topics and trends in COVID-19 research and identifying future research needs. All but 2 studies mined either PubMed or the COVID-19 Open Research Dataset. 125 Of the other 2 studies, 1 mined ClinicalTrials.gov to extract data on COVID-19-related trials, 126 while the other searched the Scopus database for a bibliometric analysis. 127 All of the studies involved NLP methods and tools (eg, word2vec, doc2vec). Some studies performed topic modeling and/or sentiment analysis. The only study that performed heterogeneous data integration was Reese et al (Table 4) , 128 in which data from 13 heterogeneous knowledge sources (eg, scientific literature, COVID-19 cases, drug, genome sequences, chemicals, etc) were downloaded, transformed, and integrated to create the KG-COVID-19 knowledge graph.

A total of 6 studies described the use of AI for social distancing or syndromic surveillance (Supplementary Table S1 ). Three of these studies analyzed data from surveillance cameras for monitoring social distancing using well-known deep learning models for object detection, [131] [132] [133] including the single-shot detector, YOLO (you only look once), and/or the regional CNN detector. Two other studies focused on analyzing Bluetooth signal strength data with linear and logistic models for contact tracing 134 or developing NLP and deep learning-based pipeline for sentinel syndromic surveillance of COVID-19 using medical records. 135 The remaining study developed a Telegram Bot that could model individualized COVID-19 risk by integrating heterogenous data, including user responses and health/social data in medical records (Table 4 ). 129 This lone study involving heterogenous data used machine learning models random forest, SVM, and GBM.

Two studies described the use of AI models in noninterventional clinical trials on COVID-19 patients (Supplementary Table S1 ). The 2 trials, namely the READY (NCT04390516) and IDENTIFY (NCT04423991), 136, 137 were conducted by the same group of investigators based on the same machine learning algorithm (an XGBoost classifier) designed to predict mechanical ventilation and mortality within 24 hours upon hospital admission using inputs from clinical data. The READY trial evaluated the performance of the algorithm, 136 while the IDENTIFY trial identified a subpopulation of COVID-19 patients who had improved survival from taking hydroxychloroquine. 137 Neither study integrated heterogenous data for modeling.

A total of 6 studies did not fall under any of the previous research topics (Supplementary Table S1 ). In the lone study that integrated heterogeneous data for modeling, Abdalla et al integrated 43 sociodemographic variables from multiple sources (eg, Census Bureau, US Department of Agriculture, Centers for Disease Control and Prevention) and built elastic net models to examine how sociodemographics impacted county-level social distancing (Table 4 ). 130 Of the remaining studies, 1 used ANN to perform a drive-through mass vaccination simulation, 138 while the other 4 used NLP methods and tools on various research topics, including cross-lingual clinical deidentification in electronic health records (EHRs), 139 dream reports analysis, 140 drug safety analysis by mining the FDA adverse event system, 141 COVID-19 clinical concept (signs and symptoms) identification, and normalization in EHRs. 142 

As governments, research communities, and healthcare industries are actively attempting to address the COVID-19 pandemic, we are tasked to identify quick yet reliable solutions for screening, diagnosis, forecasting, surveillance, the development of vaccine or drugs, and so on. On the other hand, with large amounts of COVID-19related data being collected in novel surveillance systems, AI methods have been widely employed in assisting medical experts and researchers in addressing COVID-19 challenges. In this article, we reviewed 1338 recent studies that applied AI methods or technologies in COVID-19 research. In the 794 studies included in our final qualitative analysis, we identified 7 key areas in which AI was applied. We also found that a wide range of machine learning and deep learning algorithms were used for modeling, although some were used more frequently than others depending on the area of research.

It is not at all surprising that AI methods have been used extensively in many areas of COVID-19 research. AI has been revolutionary for many analytics challenges in medicine and public health. For example, just shy of half of the studies we reviewed were studies of medical imaging analysis for assisting COVID-19 diagnosis. In fact, the use of AI in diagnostic medical imaging has been extensively explored for many diseases, such as cancer, 143 cardiovascular diseases, 144,145 lung diseases, 146 and brain diseases. 147 In these applications, AI has shown impressive sensitivity-similar to or better than expert interpretation-in identifying patterns and abnormalities in medical images that can aid diagnosis. Another major AI application in COVID-19 research is disease forecasting, with onefifth of the studies we reviewed being in this category. Compared to popular statistical time series models such as the ARIMA, AI models such as the LSTM have been proven to have superior precision and accuracy when predicting time series data, 148 without making explicit assumptions (eg, stationarity) about the data. In several other areas of COVID-19 research, AI methods are the preferred data analysis tools because of their ability to handle large amounts of heterogenous data, including text data such as those in clinical narratives or on social media. For example, in drug discovery and genomic research, AI is ideal for analyzing massive amounts of sequence data (eg, proteomic or genomic data). 149, 150 One limitation of the AI applications included in our scoping review is the lack of integration of data from heterogenous sources for modeling. In the era of precision health, it is critical to examine a comprehensive list of determinants of COVID-19 outcomes, including biological, clinical, social, behavioral, and environmental factors, that exist in various heterogeneous data sources. However, most studies we reviewed used data from a single source to perform the AI-driven tasks. For instance, over 90% of the imaging studies included in this review used data from radiological images only to build AI models for COVID-19 diagnosis. This single-sourced approach ignores other important risk factors such as clinical symptoms, exposure history, lab test results, and so on, leading to algorithms with bias (eg, confounding bias) 151 and suboptimal performance. In fact, many of the medical imaging studies that integrated heterogenous data have shown that data integration led to AI models with better performance compared to models built with imaging data alone. [53] [54] [55] 62, 65, 69, [76] [77] [78] Furthermore, although some data are difficult to get due to privacy issues or simply being unavailable, there are still a range of public data on risk factors that could be easily obtained for modeling. Many studies we reviewed leveraged the "free" data sources, such as the huge amounts of environmental data from the National Oceanic and Atmospheric Administration or the socioeconomic data from the Census Bureau. Overall, integrating heterogenous but relevant data for modeling will help realize the full potential of AI algorithms, and thus improve precision and reduce bias. Our review highlights the need for a multilevel AI framework that supports the analysis of heterogenous data from difference sources.

Our scoping review has several limitations. First, our search strategy is not as comprehensive as that of a systematic review. For example, our keyword list did not include "AI." Articles that used the abbreviation "AI" without mentioning "artificial intelligence" were not included in this review. Although we do not expect a large amount of articles being omitted, we do acknowledge this limitation in keywords. Second, we searched 2 major COVID-19 literature databases rather than the traditional databases used in systematic literature reviews. Relevant articles were often indexed in these 2 COVID-19 databases with a delay of a few days up to months. Third, we did not perform a risk of bias assessment given this is a scoping review.

Huge amounts of novel data related to COVID-19 have emerged quickly during the pandemic. As a result, AI methods and technologies have been widely applied in efforts to overcome COVID-19 challenges. In this scoping review (date of literature search: March 9, 2021), we show that a broad range of AI algorithms are used for COVID-19 research, and these algorithms are primarily used in 7 major research areas. We also show that there is a lack of data integration in these AI applications and a need for a multilevel AI framework that supports the analysis of heterogenous data from difference sources. 

JB and YG conceived the project. YZ and TL performed the literature search and article screening, with YG being the third reviewer. YZ and TL performed the information extraction and created the initial tables. YG drafted the manuscript. MP, FW, HX, and JB assisted in writing. All authors read and approved the manuscript.

Supplementary material is available at Journal of the American Medical Informatics Association online.

None.

No new data were generated in support of this research.

World Health Organization. Coronavirus disease (COVID-19)

Centers for Diseas Control and Prevention

Keep up with the latest coronavirus research

Artificial Intelligence: A Modern Approach

Machine Learning

Artificial intelligence in healthcare: past, present and future

Artificial intelligence in medicine

Artificial intelligence and Big Data in public health

Toward achieving precision health

Precision health: the role of the social and behavioral sciences in advancing the vision

How Big Data and artificial intelligence can help better manage the COVID-19 pandemic

Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: a review

Artificial intelligence for COVID-19: rapid review

Applications of artificial intelligence in battling against Covid-19: a literature review

Systematic review of artificial intelligence techniques in the detection and classification of COVID-19 medical images in terms of evaluation and benchmarking: taxonomy analysis, challenges, future solutions and methodological aspects

Global research on coronavirus disease (COVID-19

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Data integration: a theoretical perspective

An interactive web-based dashboard to track COVID-19 in real time

The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning

Impact of systematic factors on the outbreak outcomes of the novel COVID-19 disease in China: factor analysis study

Machine learning reveals that prolonged exposure to air pollution is associated with SARS-CoV-2 mortality and infectivity in Italy

Evaluating the plausible application of advanced machine learnings in exploring determinant factors of present pandemic: a case for continent specific COVID-19 analysis

Association between exposure to airborne pollutants and COVID-19 in Los Angeles, United States with ensemble-based dynamic emission model

Prioritizing and analyzing the role of climate and urban parameters in the confirmed cases of COVID-19 based on artificial intelligence applications

Exploring the growth of COVID-19 cases using exponential modelling across 42 countries and predicting signs of early containment using machine learning

COVID-19 in China: risk factors and R0 revisited

Evaluating the impact of mobility on COVID-19 pandemic with machine learning hybrid predictions

Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach

Artificial neural network modeling of novel coronavirus (COVID-19) incidence rates across the continental United States

Forecasting and planning during a pandemic: COVID-19 growth rates, supply chain disruptions, and governmental decisions

Assessment of the outbreak risk, mapping and infection behavior of COVID-19: application of the autoregressive integrated-moving average (ARIMA) and polynomial models

Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

A study of the possible factors affecting COVID-19 spread, severity and mortality and the effect of social distancing on these factors: machine learning forecasting model

Examining the effect of social distancing on the compound growth rate of COVID-19 at the county level (United States) using statistical analyses and a random forest machine learning model

Can socioeconomic, health, and safety data explain the spread of COVID-19 outbreak on Brazilian federative units?

4P model for dynamic prediction of COVID-19: a statistical and machine learning approach

Predicting and analyzing the COVID-19 epidemic in China: based on SEIRD, LSTM and GWR models

Early stage machine learningbased prediction of US county vulnerability to the COVID-19 pandemic: machine learning approach

Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India

Factors affecting COVID-19 infected and death rates inform lockdown-related policymaking

Predicting coronavirus disease 2019 infection risk and related risk drivers in nursing homes: a machine learning approach

alpha-Satellite: An AI-driven system and benchmark datasets for dynamic COVID-19 risk assessment in the United States

Assessing countries' performances against COVID-19 via WSIDEA and machine learning algorithms

Country-level pandemic risk and preparedness classification based on COVID-19 data: a machine learning approach

Using country-level variables to classify countries according to the number of confirmed COVID-19 cases: an unsupervised machine learning approach

Unsupervised learning for county-level typological classification for COVID-19 research

Development of a convolutional neural network to differentiate among the etiology of similar appearing pathological B lines on lung ultrasound: a deep learning study

COVID-19 and non-COVID-19 classification using multi-layers fusion from lung ultrasound images

Deep learning for classification and localization of COVID-19 markers in point-of-care lung ultrasound

Modality alignment contrastive learning for severity assessment of COVID-19 from lung ultrasound and clinical information

A convolutional neural network architecture for the recognition of cutaneous manifestations of COVID-19

A model based on CT radiomic features for predicting RT-PCR becoming negative in coronavirus disease 2019 (COVID-19) patients

CT quantification and machine-learning models for assessment of disease severity and prognosis of COVID-19 patients

Integrative analysis for COVID-19 patient outcome prediction

AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia

Quantitative computed tomography of the coronavirus disease 2019 (COVID-19) pneumonia

Computing SARS-CoV-2 infection risk from symptoms, imaging, and test data: diagnostic model development

Artificial intelligence matches subjective severity assessment of pneumonia for prediction of patient outcome and need for mechanical ventilation: a cohort study

A novel machine learning-derived radiomic signature of the whole lung differentiates stable from progressive COVID-19 infection: a retrospective cohort study

Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19

An improved multivariate model that distinguishes COVID-19 from seasonal flu and other respiratory diseases

Factors associated with worsening oxygenation in patient with nonsevere COVID-19 pneumonia

Chest CT for triage during COVID-19 on the emergency department: myth or truth?

Deep learning models for predicting severe progression in COVID-19-infected Patients

Prognostic implications of CT feature analysis in patients with COVID-19: a nationwide cohort study

Validation of chest computed tomography artificial intelligence to determine the requirement for mechanical ventilation and risk of mortality in hospitalized coronavirus disease-19 Patients in a tertiary care center in Mexico City

Severity of chest imaging is correlated with risk of acute neuroimaging findings among patients with COVID-19

Integrating deep learning CTscan model, biological and clinical variables to predict severity of COVID-19 patients

Prediction of COVID-19 severity using chest computed tomography and laboratory measurements: evaluation using a machine learning approach

CT radiomics facilitates more accurate diagnosis of COVID-19 pneumonia: compared with CO-RADS

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

A Deep learning prognosis model help alert for COVID-19 patients at high-risk of death: a multi-center study

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients

Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning

Automated severity assessment of COVID-19 based on clinical and imaging data: algorithm development and validation

Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis

CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings

A rapid screening classifier for diagnosing COVID-19

Accurately differentiating between patients with COVID-19, patients with other viral infections, and healthy individuals: multimodal late fusion learning approach

A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients

Development of machine learning models to predict RT-PCR results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with influenza-like symptoms using only basic clinical data

An artificial intelligence-based firstline defence against COVID-19: digitally screening citizens for risks via a chatbot

Indicators of acute kidney injury as biomarkers to differentiate heatstroke from coronavirus disease 2019: a retrospective multicenter analysis

An IoTbased framework for early identification and monitoring of COVID-19 cases

Artificial intelligence enabled preliminary diagnosis for COVID-19 from voice cues and questionnaires

Applying the electronic nose for pre-operative SARS-CoV-2 screening

Machine learning-based prediction of COVID-19 diagnosis based on symptoms

A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea

Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study

Intensive care risk estimation in COVID-19 pneumonia based on clinical and imaging parameters: experiences from the Munich cohort

Using machine learning to predict ICU transfer in hospitalized COVID-19 patients

Predicting CoVID-19 community mortality risk using machine learning and development of an online prognostic tool

Predicting psychological state among Chinese undergraduate students in the COVID-19 epidemic: a longitudinal study using a machine learning

Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation

Early prediction of mortality risk among patients with severe COVID-19, using machine learning

COVID-19 patient health prediction using boosted random forest algorithm

Predict mortality in patients infected with COVID-19 virus based on observed characteristics of the patient using logistic regression

Individual-level fatality prediction of COVID-19 patients using AI methods

Early triage of critically ill COVID-19 patients using deep learning

Development and validation of prognosis model of mortality risk in patients with COVID-19

Survival analysis of COVID-19 patients in Russia using machine learning

Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection

Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19

Natural language processing for rapid response to emergent diseases: case study of calcium channel blockers and hypertension in the COVID-19 pandemic

Machine learning based predictors for COVID-19 disease severity

Deep phenotyping of headache in hospitalized COVID-19 patients via principal component analysis

Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario

A prediction model of outcome of SARS-CoV-2 pneumonia based on laboratory findings

DrugBank: a knowledgebase for drugs, drug actions and drug targets

ChEMBL: a large-scale bioactivity database for drug discovery

PubChem substance and compound databases

ZINC -a free database of commercially available compounds for virtual screening

BindingDB: a webaccessible database of experimentally determined protein-ligand binding affinities

Bioactivity profile similarities to expand the repertoire of COVID-19 Drugs

The anatomy of the SARS-CoV-2 biomedical literature: introducing the CovidX network algorithm for drug repurposing recommendation

Toward preparing a knowledge base to explore potential drugs and biomedical entities related to COVID-19: automated computational approach

Repurpose open data to discover therapeutics for COVID-19 using deep learning

Drug repurposing for COVID-19 via knowledge graph completion

The protein data bank

Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021

Cross-sectional analysis to explore the awareness, attitudes and actions of UK adults at high risk of severe illness from COVID-19

Use of artificial intelligence to understand adults' thoughts and behaviours relating to COVID-19

CORD-19: The Covid-19 open research dataset

Analysis of COVID-19 clinical trials: a data-driven, ontologybased, and natural language processing approach

Coronavirus disease (COVID-19): a machine learning bibliometric analysis

KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response

Shifting the paradigm: The Dress-COV telegram bot as a tool for participatory medicine

Asynchrony between individual and government actions accounts for disproportionate impact of COVID-19 on vulnerable communities

Implementing a real-time, AIbased, people detection and social distancing measuring system for Covid-19

Towards the sustainable development of smart cities through mass video surveillance: a response to the COVID-19 pandemic

Analysis of pedestrian activity before and during COVID-19 lockdown, using webcam time-lapse from Cracow and machine learning

Risk estimation of SARS-CoV-2 transmission from bluetooth low energy measurements

An aberration detection-based approach for sentinel syndromic surveillance of COVID-19 and other novel influenza-like illnesses

Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial

Is Machine learning a better way to identify COVID-19 patients who might benefit from hydroxychloroquine treatment?-The IDENTIFY Trial

Artificial intelligence model of drive-through vaccination simulation

Crosslingual named entity recognition for clinical de-identification applied to a COVID-19 Italian data set

Dreaming during the Covid-19 pandemic: computational assessment of dream reports reveals mental suffering related to fear of contagion

Assessment of the potential adverse events related to ribavirin-interferon combination for novel coronavirus therapy

COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model

Multimodality imaging and artificial intelligence for tumor characterization: current status and future perspective

Application and translation of artificial intelligence to cardiovascular imaging in nuclear medicine and noncontrast CT

Applications of artificial intelligence in multimodality cardiovascular imaging: a state-of-theart review

Survey on deep learning for pulmonary medical imaging

Applications of deep learning to neuro-imaging techniques

A Comparison of ARIMA and LSTM in Forecasting Time Series

Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology

Machine learning applications in genetics and genomics

Bias in analytic research

None declared.